Start Date: ,
End Date: ,
Click here to access the article.
The practice of minimally invasive cardiac surgery (MICS) is needed to sustain the ongoing growth and success of our field. The past several years have witnessed sweeping change in cardiac surgery with the widespread adoption of percutaneous transcatheter aortic valve replacement. In addition, percutaneous edge-to-edge repair of the mitral valve along with other emerging mitral disease technologies are poised for expansion. MICS will enable cardiac surgeons to remain at the forefront of cardiovascular disease by offering patients the most well-tested and durable treatments possible while minimizing morbidity and hospital stay.1,2 Practices and techniques continue to evolve alongside innovative technologies that will help propel MICS to new frontiers.